微小RNA-103及RNA-107表达与120例脓毒症患者临床特征及预后的关联分析

doi:10.6040/j.issn.1671-7554.0.2020.0110

摘要/Abstract

摘要： 目的评估血浆微小RNA-103(miR-103)和RNA-107(miR-107)对脓毒症患病死亡风险的预判,并探讨其与脓毒症患者疾病严重程度及预后有关联的因素。方法选取2016年1月至2019年6月接受治疗的脓毒症患者120例(脓毒症组),入院24 h之内收集血液样本;选取同期健康对照者120例(健康对照组),入组时收集血液样本,并分离血液样本中血浆。采用反转录-荧光定量聚合酶链式反应检测所有受试者血浆miR-103和miR-107的表达水平。采用酶联免疫吸附试剂盒检测脓毒症组血浆中某些炎症因子的表达水平。收集脓毒症组临床指标并计算其28 d死亡率。采用受试者工作曲线(ROC)对临床辅助诊断的预判分析,采用Coxs回归模型分析脓毒血症死亡的关联因素。结果 miR-103和miR-107在脓毒症组表达水平相比健康对照组均降低,且可作为脓毒症临床诊断的辅助指标,其曲线下面积(AUC)分别为0.893(95%CI:0.854~0.933)及0.941(95%CI:0.913~0.968)。脓毒症组miR-103和miR-107表达水平与急性生理和慢性健康状态II评分、序贯器官功能衰竭评分、血清肌酐、C-反应蛋白、肿瘤坏死因子-α、白介素-1β、白介素-6及白介素-8均呈负相关,与白蛋白呈正相关。此外,miR-103和miR-107在脓毒症死亡患者中表达水平较脓毒症存活患者降低。多元Coxs回归分析结果显示,miR-103表达是预测脓毒症组28 d死亡率的独立因素。结论 miR-103和miR-107低表达与脓毒症相关,并与脓毒症患者疾病严重程度及28 d死亡率相关。

关键词: 微小RNA-103, 微小RNA-107, 脓毒症, 疾病严重程度, 炎症, 28 d死亡率

Abstract: Objective To evaluate the predictive values of plasma microRNA(miR)-103 and miR-107 for septic death, and their correlations with disease severity as well as prognosis. Methods A total of 120 sepsis patients who received treatment in our hospital during Jan. 2016 and Jun. 2019(sepsis group)were enrolled and their plasma samples were collected within 24 h after enrollment; meanwhile, 120 contemporaneous healthy controls(HC group)were recruited and their plasma samples were collected. Plasma miR-103 and miR-107 expressions were detected with reverse transcription-quantitative polymerase chain reaction. Several plasma inflammatory cytokines were detected with enzyme-linked immune sorbent assay. In sepsis patients, clinical characteristics were collected and 28-day mortality rate was calculated. The supportive diagnostic value for sepsis was analyzed with receiver operating characteristic(ROC)curve. The associated factors of sepsis death were analyzed with multivariate Coxs regression model. Results The sepsis group had reduced miR-103 and miR-107 expressions than HC group. The miR-103 and miR-107 expressions could serve as supportive indexes for sepsis diagnosis, and their area under curve(AUC)was 0.893(95%CI: 0.854-0.933)and 0.941(95%CI: 0.913-0.968), respectively. In sepsis group, miR-103 and miR-107 expressions were negatively correlated with acute pathologic and chronic health evaluation II score, sequential organ failure assessment score, serum creatinine, C-reactive protein, tumor necrosis factor-α, interleukin-1β, interleukin-6 and interleukin-8, while positively correlated with albumin. Moreover, miR-103 and miR-107 expressions decreased in septic deaths compared to septic survivors. Multivariate Coxs regression analysis revealed that miR-103 expression was an independent factor for 28-day mortality risk of sepsis patients. Conclusion Reduced miR-103 and miR-107 expressions are correlated with sepsis incidence, as well as disease severity and 28-day mortality.

Key words: microRNA-103, microRNA-107, Sepsis, Disease severity, Inflammation, 28-day mortality

中图分类号:

R459.7

杨珍,张艳敏,王倩倩,陈惠敏,冯强,周少英. 微小RNA-103及RNA-107表达与120例脓毒症患者临床特征及预后的关联分析[J]. 山东大学学报 (医学版), 2020, 58(12): 77-85.

YANG Zhen, ZHANG Yanmin, WANG Qianqian, CHEN Huimin, FENG Qiang, ZHOU Shaoying. Correlations of microRNA-103 and microRNA-107 expressions with the clinical characteristics and prognosis of 120 cases of sepsis[J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 77-85.

参考文献

[1] Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock(sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
[2] Tiru B, DiNino EK, Orenstein A, et al. The economic and humanistic burden of severe sepsis [J]. Pharmacoeconomics, 2015, 33(9): 925-937.
[3] Howell MD, Davis AM. Management of sepsis and septic shock [J]. JAMA, 2017, 317(8): 847-848.
[4] Verdonk F, Blet A, Mebazaa A. The new sepsis definition: limitations and contribution to research and diagnosis of sepsis [J]. Curr Opin Anaesthesiol, 2017, 30(2): 200-204.
[5] Finnerty JR, Wang WX, Hebert SS, et al. The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases [J]. J Mol Biol, 2010, 402(3): 491-509.
[6] Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways [J]. Mol Genet Metab, 2007, 91(3): 209-217.
[7] Zhang W, Deng W, Wang Y. microRNA-103 promotes LPS-induced inflammatory injury by targeting c-Myc in HK-2 cells [J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 2791-2799.
[8] Hsieh CH, Rau CS, Jeng JC, et al. Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides [J]. J Biomed Sci, 2012, 19(1): 69.
[9] Gao ZF, Ji XL, Gu J, et al. microRNA-107 protects against inflammation and endoplasmic reticulum stress of vascular endothelial cells via KRT1-dependent Notch signaling pathway in a mouse model of coronary atherosclerosis [J]. J Cell Physiol, 2019, 234(7): 12029-12041.
[10] Lu Q, Ma Z, Ding Y, et al. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-kappaB/p65 regulatory axis [J]. Nat Commun, 2019, 10(1): 2145.
[11] Wang S, Zhang Z, Wang J, et al. MiR-107 induces TNF-alpha secretion in endothelial cells causing tubular cell injury in patients with septic acute kidney injury [J]. Biochem Biophys Res Commun, 2017, 483(1): 45-51.
[12] Wang JX, Zhang XJ, Li Q, et al. MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD [J]. Circ Res, 2015, 117(4): 352-363.
[13] Marialbert AH, Fabian LD, Maria PY, et al. Lung transcriptomics during protective ventilatory support in sepsis-induced acute lung injury [J]. PLoS One, 2015, 10(7): e0132296.
[14] Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 [J]. Intensive Care Med, 2013, 39(2): 165-228.
[15] Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system [J]. Crit Care Med, 1981, 9(8): 591-597.
[16] Vincent JL, Moreno R, Takala J, et al. The SOFA(sepsis-related organ failure assessment)score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine [J]. Intensive Care Med, 1996, 22(7): 707-710.
[17] 章春霞, 廉姜芳. MiR-103功能的研究进展[J]. 生命的化学, 2018, 38(1): 104-108. ZHANG Chunxia, LIAN Jiangfang. Research progress on the roles of miR-103[J]. Chemistry of life,2018, 38(1): 104-108.
[18] Li G, Chen T, Zhu Y, et al. MiR-103 alleviates autophagy and apoptosis by regulating SOX2 in LPS-injured PC12 cells and SCI rats [J]. Iran J Basic Med Sci, 2018, 21(3): 292-300.
[19] 师灵灵, 韩艳秋, 任慧娟, 等. 脓毒症的病理生理机制研究进展 [J]. 中华医院感染学杂志, 2016, 26(8): 1914-1916. SHI Lingling, HAN Yanqiu, REN Huijuan, et al. Research advance of pathology and physiology of sepsis[J]. Chinese Journal of Nosocomiology, 2016, 26(8): 1914-1916.
[20] 曾小娜, 尹连红, 许丽娜. 脓毒症性急性肾损伤发病机制[J]. 生理科学进展, 2020, 51(2): 44-48.

相关文章 15

[1]	徐宁宇王磊郝恩魁苏国海. STEMI患者急诊PCI前口服阿托伐他汀对炎症介质及左心室功能的影响[J]. 山东大学学报(医学版), 2209, 47(6): 69-72.
[2]	郝跃伟刘雪平赵婷婷郑敏王一兵. 环氧化酶2基因多态性与动脉粥样硬化缺血性脑卒中的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 95-98.
[3]	李晓琪,刘佩丽,成红,赵艳艳. 基于自注意力机制预测ICU脓毒症患者的死亡率[J]. 山东大学学报 (医学版), 2025, 63(8): 86-93.
[4]	赵灿斌,邵将,管东辉,秦英,丁强,郭良,王伟伟,陈威,闫小龙,曾平. 木犀草素在炎症微环境下调控Wnt/β-catenin信号通路促进骨髓间充质干细胞成软骨分化的机制[J]. 山东大学学报 (医学版), 2025, 63(7): 11-22.
[5]	贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[6]	张舒淇,江延姣,印丹. 生殖道微生物与子宫内膜异位症发展之间的联系[J]. 山东大学学报 (医学版), 2025, 63(5): 120-126.
[7]	杜艾家,张曼,陈鹤,王丽新,尚应殊. 微小RNA-1270靶向调控血管生成素样蛋白7抑制巨噬细胞炎症和脂质蓄积[J]. 山东大学学报 (医学版), 2025, 63(2): 1-9.
[8]	徐萍,张信美. 子宫内膜异位症疼痛的机制[J]. 山东大学学报 (医学版), 2025, 63(10): 1-7.
[9]	梁炎春,严莹,麦华希,姚书忠. 地诺孕素在子宫内膜异位症相关性疼痛中的治疗作用:从基础到临床[J]. 山东大学学报 (医学版), 2025, 63(10): 27-33.
[10]	孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80.
[11]	刘绍庭,张薇薇,冉茜,王建. 食品乳化剂与肠道健康[J]. 山东大学学报 (医学版), 2024, 62(8): 18-26.
[12]	孙丽娜,白红艳,牛宗格,张福帅,曲仪庆. 基于SII构建及评价预测ARDS住院死亡率的在线临床风险模型[J]. 山东大学学报 (医学版), 2024, 62(7): 10-20.
[13]	田丽君,桑玉洁,孙瑜婧,韩冰,秦成勇,祁建妮. 全身免疫炎症指数对原发性肝癌患者免疫检查点抑制剂治疗相关不良反应的预测价值[J]. 山东大学学报 (医学版), 2024, 62(6): 48-53.
[14]	沈海涛,乔亚琴,董萍,路燕. Toll样受体4调控的程序性坏死和铁死亡对对乙酰氨基酚肝损伤的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 1-8.
[15]	徐新军,邵丽婷,陈颖,刘会芳,杨玉娟,张宇,王浛睿,宋西成. SYN008与Xolair^®对过敏性哮喘小鼠治疗作用效果比较:炎症与重塑[J]. 山东大学学报 (医学版), 2024, 62(12): 1-10.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed